Maen Masadeh1, Subhash Chandra2, Daniel Livorsi3, Frederick Johlin1, William Silverman4,5. 1. Division of Gastroenterology and Hepatology, Department of Internal Medicine, University of Iowa Hospitals and Clinics, 4544 JCP, 200 Hawkins Drive, Iowa City, IA, 52242, USA. 2. Department of Internal Medicine, Creighton University, 18717 Nicholas Street, Elkhorn, NE, 68022, USA. 3. Division of Infectious Diseases, Department of Internal Medicine, University of Iowa Hospitals and Clinics, SW 34-G GH, 200 Hawkins Drive, Iowa City, IA, 52242, USA. 4. Division of Gastroenterology and Hepatology, Department of Internal Medicine, University of Iowa Hospitals and Clinics, 4544 JCP, 200 Hawkins Drive, Iowa City, IA, 52242, USA. william-silverman@uiowa.edu. 5. Department of Internal Medicine, University of Iowa Hospitals and Clinics, 4553 JCP, 200 Hawkins Drive, Iowa City, IA, 52242, USA. william-silverman@uiowa.edu.
Abstract
BACKGROUND: Bacteremia due to cholangitis can occur as a complication of biliary instrumentation. Biliary sepsis can result from frequent endoscopic retrograde cholangiopancreatography (ERCP). METHODS: We hypothesized that routine use of antibiotics in patients who require frequent ERCPs leads to cholangitis resistant to empiric antibiotics used to treat biliary sepsis. We retrospectively reviewed patients with frequent biliary instrumentation and blood stream infection due to cholangitis. Conventional empiric antibiotics were defined as broad-spectrum antibacterial agents predominantly used for community-acquired infections and surgical prophylaxis. Broad-spectrum antibacterial agents used for hospital-onset/multidrug-resistant infections were defined as broad-spectrum MDR antibiotics. RESULTS: Seventy-eight patients had bacteremia secondary to cholangitis from biliary obstruction. Over 50% of bacteria were not sensitive to conventional empiric antibiotics for biliary sepsis. Thirty-seven patients did not receive post-procedural antibiotics and forty-one patients did. Of the ones who did, 58% later had a bloodstream infection with bacteria resistant to the antibiotic used for prophylaxis, and 26 patients (63%) required a broad-spectrum MDR antibiotic for treatment. The number of ERCPs was not associated with resistance to prophylactic antibiotics (p 0.7103) or needing broad-spectrum MDR antibiotics for treatment of cholangitis-associated bacteremia (p 0.1868). Routine use of antibiotic prophylaxis after ERCP was associated with trend toward need for broad-spectrum MDR antibiotics for cholangitis-associated bacteremia, Chi-square 3.7, 0 0.0540. CONCLUSION: Bacterial resistance to conventional empiric antibiotics is an emerging problem. Blood cultures are needed to guide therapy.
BACKGROUND:Bacteremia due to cholangitis can occur as a complication of biliary instrumentation. Biliary sepsis can result from frequent endoscopic retrograde cholangiopancreatography (ERCP). METHODS: We hypothesized that routine use of antibiotics in patients who require frequent ERCPs leads to cholangitis resistant to empiric antibiotics used to treat biliary sepsis. We retrospectively reviewed patients with frequent biliary instrumentation and blood stream infection due to cholangitis. Conventional empiric antibiotics were defined as broad-spectrum antibacterial agents predominantly used for community-acquired infections and surgical prophylaxis. Broad-spectrum antibacterial agents used for hospital-onset/multidrug-resistant infections were defined as broad-spectrum MDR antibiotics. RESULTS: Seventy-eight patients had bacteremia secondary to cholangitis from biliary obstruction. Over 50% of bacteria were not sensitive to conventional empiric antibiotics for biliary sepsis. Thirty-seven patients did not receive post-procedural antibiotics and forty-one patients did. Of the ones who did, 58% later had a bloodstream infection with bacteria resistant to the antibiotic used for prophylaxis, and 26 patients (63%) required a broad-spectrum MDR antibiotic for treatment. The number of ERCPs was not associated with resistance to prophylactic antibiotics (p 0.7103) or needing broad-spectrum MDR antibiotics for treatment of cholangitis-associated bacteremia (p 0.1868). Routine use of antibiotic prophylaxis after ERCP was associated with trend toward need for broad-spectrum MDR antibiotics for cholangitis-associated bacteremia, Chi-square 3.7, 0 0.0540. CONCLUSION: Bacterial resistance to conventional empiric antibiotics is an emerging problem. Blood cultures are needed to guide therapy.
Authors: Mouen A Khashab; Krishnavel V Chithadi; Ruben D Acosta; David H Bruining; Vinay Chandrasekhara; Mohamad A Eloubeidi; Robert D Fanelli; Ashley L Faulx; Lisa Fonkalsrud; Jenifer R Lightdale; V Raman Muthusamy; Shabana F Pasha; John R Saltzman; Aasma Shaukat; Amy Wang; Brooks D Cash Journal: Gastrointest Endosc Date: 2014-11-11 Impact factor: 9.427
Authors: Rungsun Rerknimitr; Evan L Fogel; Cem Kalayci; Edward Esber; Glen A Lehman; Stuart Sherman Journal: Gastrointest Endosc Date: 2002-12 Impact factor: 9.427
Authors: Cori L Ofstead; Brandy L Buro; Krystina M Hopkins; John E Eiland; Harry P Wetzler; David R Lichtenstein Journal: Endosc Int Open Date: 2020-11-17
Authors: Sonia Bianchini; Erika Rigotti; Sara Monaco; Laura Nicoletti; Cinzia Auriti; Elio Castagnola; Giorgio Conti; Luisa Galli; Mario Giuffrè; Stefania La Grutta; Laura Lancella; Andrea Lo Vecchio; Giuseppe Maglietta; Nicola Petrosillo; Carlo Pietrasanta; Nicola Principi; Simonetta Tesoro; Elisabetta Venturini; Giorgio Piacentini; Mario Lima; Annamaria Staiano; Susanna Esposito Journal: Antibiotics (Basel) Date: 2022-02-21